1. Home
  2. NLSP vs DTSS Comparison

NLSP vs DTSS Comparison

Compare NLSP & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • DTSS
  • Stock Information
  • Founded
  • NLSP 2015
  • DTSS 2014
  • Country
  • NLSP Switzerland
  • DTSS China
  • Employees
  • NLSP N/A
  • DTSS N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • DTSS Technology
  • Exchange
  • NLSP Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • NLSP 12.4M
  • DTSS 16.5M
  • IPO Year
  • NLSP 2021
  • DTSS N/A
  • Fundamental
  • Price
  • NLSP $2.86
  • DTSS $1.96
  • Analyst Decision
  • NLSP
  • DTSS
  • Analyst Count
  • NLSP 0
  • DTSS 0
  • Target Price
  • NLSP N/A
  • DTSS N/A
  • AVG Volume (30 Days)
  • NLSP 365.2K
  • DTSS 81.1K
  • Earning Date
  • NLSP 07-07-2025
  • DTSS 05-14-2025
  • Dividend Yield
  • NLSP N/A
  • DTSS N/A
  • EPS Growth
  • NLSP N/A
  • DTSS N/A
  • EPS
  • NLSP N/A
  • DTSS N/A
  • Revenue
  • NLSP N/A
  • DTSS $56,255,129.00
  • Revenue This Year
  • NLSP N/A
  • DTSS N/A
  • Revenue Next Year
  • NLSP N/A
  • DTSS N/A
  • P/E Ratio
  • NLSP N/A
  • DTSS N/A
  • Revenue Growth
  • NLSP N/A
  • DTSS 144.20
  • 52 Week Low
  • NLSP $1.30
  • DTSS $1.63
  • 52 Week High
  • NLSP $15.59
  • DTSS $7.67
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 67.56
  • DTSS 40.28
  • Support Level
  • NLSP $2.19
  • DTSS $1.91
  • Resistance Level
  • NLSP $2.54
  • DTSS $2.18
  • Average True Range (ATR)
  • NLSP 0.19
  • DTSS 0.14
  • MACD
  • NLSP 0.02
  • DTSS -0.03
  • Stochastic Oscillator
  • NLSP 82.76
  • DTSS 15.09

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: